Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension.
- 17 August 2000
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 75 (1) , 43-47
- https://doi.org/10.1016/s0167-5273(00)00274-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Inhibition of tumour cell invasion by protease inhibitors: correlation with the protease profileZeitschrift für Krebsforschung und Klinische Onkologie, 1998
- Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human HeartCirculation, 1998
- Abnormalities of the Extracellular Degradation of Collagen Type I in Essential HypertensionCirculation, 1998
- Expression of matrix metalloproteinase 9 (96‐kd gelatinase B) in human rheumatoid arthritisArthritis & Rheumatism, 1996
- Matrix Metalloproteinases and Cardiovascular DiseaseCirculation Research, 1995
- Myocardial fibrosis in hypertensive heart disease: an overview of potential regulatory machanismsEuropean Heart Journal, 1995
- Identification of 92-kD Gelatinase in Human Coronary Atherosclerotic LesionsCirculation, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle.Circulation Research, 1989
- Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.Circulation, 1977